FDA Approved: JALYN — Original Application (Waylis Therapeutics)

View source ↗

Summary

FDA approved JALYN, a fixed-dose combination of dutasteride and tamsulosin hydrochloride, from Waylis Therapeutics via an Original Application for benign prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• JALYN (dutasteride and tamsulosin hydrochloride)

Snippet

ORIG AP for JALYN (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE)